Title: Charles Sherard Irving: Innovator in Retinal Disease Treatment
Introduction
Charles Sherard Irving is an inventor based in Caesarea, IL. He is currently associated with Cell Cure Neurosciences Ltd. Despite having no granted patents, his contributions to the field of retinal disease treatment are noteworthy.
Latest Patent Applications
Irving's latest patent applications include a method for treating subjects with dry-form age-related macular degeneration (AMD). This method involves administering a therapeutically effective amount of a pharmaceutical composition comprising human RPE cells into the subretina of the subject. The cells must co-express premelanosome protein (PMEL17) and cellular retinaldehyde binding protein (CRALBP), with a trans-epithelial electrical resistance greater than 100 ohms. This innovative approach aims to provide effective treatment for individuals suffering from this condition.
Conclusion
Charles Sherard Irving is making significant strides in the treatment of retinal diseases through his innovative methods. His work at Cell Cure Neurosciences Ltd. highlights the potential for advancements in medical treatments for age-related conditions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.